<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02338739</url>
  </required_header>
  <id_info>
    <org_study_id>1R01MH104123-01</org_study_id>
    <nct_id>NCT02338739</nct_id>
  </id_info>
  <brief_title>An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care (AdaPT-R) in Nyanza, Kenya</brief_title>
  <acronym>AdaPT-R</acronym>
  <official_title>An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care (AdaPT-R)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Berkeley</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kenya Medical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retaining HIV-infected patients in care is critical, but loss to follow-up after enrolment
      often reaches 20%-40% by two years, placing millions of patients at risk of poor outcomes. A
      strategy to optimize retention within resource constraints is urgently needed. Sequential
      adaptive strategies - a novel class of public health approaches - may offer a solution. A
      candidate sequential adaptive strategy would start with a less expensive intervention (e.g.,
      SMS) in all patients and then apply a more costly and intensive one (e.g., navigator) only to
      patients who show early signs of poor retention. This study involves a sequential multiple
      assignment randomized trial to evaluate a family of such strategies. the investigators will
      randomize 1,800 adults newly initiating antiretroviral treatment (ART) at 4 HIV clinics in
      the Nyanza region of Kenya to (1) standard of care routine education and counselling (REC),
      (2) SMS text messages, or (3) transport vouchers. Patients with early signs of weakening
      retention (defined as the first time a patient is 14 days late for an appointment) will be
      re-randomized to (1) a single episode of outreach (standard of care), (2) SMS combined with
      vouchers, or (3) a peer navigator. Patients not successfully contacted by 28 days after
      missed visit (and not verified to have left the area or transferred to another clinic) will
      also be rerandomized to of one the same three re-engagement interventions. Individuals
      randomized at first stage to SMS or voucher that do not miss a visit by at least 14 days in
      the first 12 months of follow up will be re-randomized at 12 months to stop first stage
      intervention or continue with that same intervention to 24 months. The investigators primary
      objective is to assess the comparative effectiveness of sequenced intervention strategies to
      prevent initial lapses in retention and to treat those that occur. The investigators primary
      endpoint is fraction of time retained in care two years after enrolment. In addition, the
      investigators will assess the comparative effectiveness of first-stage strategies (REC, SMS,
      voucher) to prevent lapses in retention, and the comparative effectiveness of second stage
      strategies (outreach, SMS + voucher, navigator) to re-engage patients after initial lapse.
      This study will also compare outcomes among patients who continue versus discontinue the SMS
      and voucher interventions, including a small complementarity component utilizing qualitative
      methods to examine the voucher approach and the effects of discontinuing this approach after
      success among a subset of participants. At study conclusion the investigators output will be
      a menu of adaptive strategies for retention, accompanied by estimates of cost and
      effectiveness, which policy makers in different settings can use to advance the impact of HIV
      care and treatment programs in Africa.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Retention</measure>
    <time_frame>Up to two years after enrollment</time_frame>
    <description>Fraction of time in care</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alive with suppressed HIV RNA level (&lt;400 copies/ml)</measure>
    <time_frame>Two years after study enrollment</time_frame>
    <description>Number of subjects alive with suppressed HIV RNA levels (&lt;400 copies/ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from second randomization to return to clinic after initial retention lapse</measure>
    <time_frame>Up to two years after enrollment</time_frame>
    <description>Time from second randomization to re-engagement; re-engagement is defined as first visit back to clinic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean visit adherence (% visits made)</measure>
    <time_frame>Two years after study enrollment</time_frame>
    <description>Proportion of kept scheduled appointments (range=0-100%), with kept visits being those attended by the patient and with the denominator excluding canceled visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retention</measure>
    <time_frame>Two years after enrollment</time_frame>
    <description>Fraction of time in care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fraction on-time pharmacy pick-ups for antiretroviral drugs</measure>
    <time_frame>Two years after enrollment</time_frame>
    <description>Proportion of prescriptions filled and picked up by participants to prescriptions written</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness</measure>
    <time_frame>After two years of enrollment</time_frame>
    <description>Cost per failure (virological failure (HIV RNA&gt;=400 copies/ml) or death averted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported barriers to engagement</measure>
    <time_frame>At years one and two after study enrollment</time_frame>
    <description>Self-reported by questionnaire</description>
  </secondary_outcome>
  <number_of_arms>15</number_of_arms>
  <enrollment type="Anticipated">1800</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>REC; Outreach if Failure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>REC; SMS + Voucher if Failure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>REC; Navigator if Failure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS; Outreach if Failure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS; Outreach if Failure; Stop SMS if Success</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS; SMS+Voucher if Failure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS; SMS+Voucher if Failure; Stop SMS if Success</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS; Navigator if Failure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS; Navigator if Failure; Stop SMS if Success</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Voucher; Outreach if Failure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Voucher; Outreach if Failure; Stop Voucher if Success</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Voucher; SMS+Voucher if Failure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Voucher; SMS+Voucher if Failure; Stop Voucher if Success</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Voucher; Navigator if Failure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Voucher; Navigator if Failure; Stop Voucher if Success</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>REC; Outreach if Failure</intervention_name>
    <description>Routine education and counseling (REC) services, delivered per Kenya Ministry of Health Guidelines; followed by standard of care (SOC) outreach to encourage return to clinic for patients 14 days late for a scheduled visit in year 1.</description>
    <arm_group_label>REC; Outreach if Failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>REC; SMS + Voucher if Failure</intervention_name>
    <description>Routine education and counseling services, delivered per Kenya Ministry of Health (MOH) Guidelines; followed by SMS text messages for patients and reimbursement at a fixed amount (KSH 400) for transport to the clinic for patients 14 days late for a scheduled visit in year 1.</description>
    <arm_group_label>REC; SMS + Voucher if Failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>REC; Navigator if Failure</intervention_name>
    <description>REC services, delivered per Kenya MOH Guidelines; followed by Peer Navigator (tailored outreach and support) for patients 14 days late for a scheduled visit</description>
    <arm_group_label>REC; Navigator if Failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS; Outreach if Failure</intervention_name>
    <description>SMS text messages for patients; followed by SOC outreach for patients 14 days late for a scheduled visit</description>
    <arm_group_label>SMS; Outreach if Failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS; Outreach if Failure; Stop SMS if Success</intervention_name>
    <description>SMS text messages for patients, followed by SOC outreach for patients 14 days late for a scheduled visit, and discontinuation of SMS text messages if never 14 days late</description>
    <arm_group_label>SMS; Outreach if Failure; Stop SMS if Success</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS; SMS+Voucher if Failure</intervention_name>
    <description>SMS text messages for patients, followed by reimbursement at a fixed amount (KSH 400) for transport to the clinic for patients 14 days late for a scheduled visit in year 1.</description>
    <arm_group_label>SMS; SMS+Voucher if Failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS; SMS+Voucher if Failure; Stop SMS if Success</intervention_name>
    <description>SMS text messages for patients, followed by reimbursement at a fixed amount (KSH 400) for transport to the clinic for patients 14 days late for a scheduled visit in year 1, and discontinuation of SMS text messages if never 14 days late</description>
    <arm_group_label>SMS; SMS+Voucher if Failure; Stop SMS if Success</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS; Navigator if Failure</intervention_name>
    <description>SMS text messages for patents, followed by Peer Navigator (tailored outreach and support) for patients 14 days late for a scheduled visit</description>
    <arm_group_label>SMS; Navigator if Failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS; Navigator if Failure; Stop SMS if Success</intervention_name>
    <description>SMS text messages for patents, followed by Peer Navigator (tailored outreach and support) for patients 14 days late for a scheduled visit, and discontinuation of SMS text messages if never 14 days late</description>
    <arm_group_label>SMS; Navigator if Failure; Stop SMS if Success</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voucher; Outreach if Failure</intervention_name>
    <description>Reimbursement at a fixed amount (KSH 400) for transport to the clinic for patients, followed by SOC outreach for patients 14 days late for a scheduled visit</description>
    <arm_group_label>Voucher; Outreach if Failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voucher; Outreach if Failure; Stop Voucher if Success</intervention_name>
    <description>Reimbursement at a fixed amount (KSH 400) for transport to the clinic for patients, followed by SOC outreach for patients 14 days late for a scheduled visit, and discontinuation of voucher for patients if never 14 days late</description>
    <arm_group_label>Voucher; Outreach if Failure; Stop Voucher if Success</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voucher; SMS+Voucher if Failure</intervention_name>
    <description>Reimbursement at a fixed amount (KSH 400) for transport to the clinic for patients, followed by SMS text message and reimbursement (KSH 400) for transport to the clinic for patients 14 days late for a scheduled visit</description>
    <arm_group_label>Voucher; SMS+Voucher if Failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voucher; SMS+Voucher if Failure; Stop Voucher if Success</intervention_name>
    <description>Reimbursement at a fixed amount (KSH 400) for transport to the clinic for patients, followed by SMS text message and reimbursement (KSH 400) for transport to the clinic for patients 14 days late for a scheduled visit, and discontinuation of voucher for patients if never 14 days late</description>
    <arm_group_label>Voucher; SMS+Voucher if Failure; Stop Voucher if Success</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voucher; Navigator if Failure</intervention_name>
    <description>Reimbursement at a fixed amount (KSH 400) for transport to the clinic for patients, followed by Peer Navigator (tailored outreach and support) for patients 14 days late for a scheduled visit</description>
    <arm_group_label>Voucher; Navigator if Failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voucher; Navigator if Failure; Stop Voucher if Success</intervention_name>
    <description>Reimbursement at a fixed amount (KSH 400) for transport to the clinic for patients, followed by Peer Navigator (tailored outreach and support) for patients 14 days late for a scheduled visit, and discontinuation of voucher for patients if never 14 days late</description>
    <arm_group_label>Voucher; Navigator if Failure; Stop Voucher if Success</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV-infection

          -  18 years old

          -  Planning to remain in the study area (Nyanza region) for the duration of the study,
             capable of informed consent

          -  Newly initiating ART (within past 90 days)

          -  Access to a cell phone

          -  Ability to read or be read SMS messages

          -  And willingness to be contacted by clinic upon missed appointment.

        Exclusion Criteria:

          -  Plans to move out of Nyanza region or acutely ill and requiring hospitalization.

          -  Hospitalized patients who later recover will be eligible for enrolment at the first
             post-hospitalization clinic visit during which eligibility criteria are met.

          -  No access to a cell phone.

          -  Involvement in studies with the potential to influence retention behaviors.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elvin Geng, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maya Petersen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Berkeley</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jayne A Lewis Kulzer, MPH</last_name>
    <phone>+18055743737</phone>
    <email>jayne.kulzer@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Odeny, MBChB, MPH</last_name>
    <phone>+254722819835</phone>
    <email>taodeny@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kenya Medical Research Institute</name>
      <address>
        <city>Kisumu</city>
        <state>Nyanza</state>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Odeny, MBChB, MPH</last_name>
      <phone>+254722740076</phone>
      <email>taodeny@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jayne A Lewis Kulzer, MPH</last_name>
      <phone>+1805 574 3737</phone>
      <email>jayne.kulzer@ucsf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Elizabeth A Bukusi, MBChB, M.Med, MPH, PhD, PGD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Odeny, MBChB, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Kenya</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2014</study_first_submitted>
  <study_first_submitted_qc>January 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2015</study_first_posted>
  <last_update_submitted>November 2, 2017</last_update_submitted>
  <last_update_submitted_qc>November 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Retention</keyword>
  <keyword>Lost to follow up</keyword>
  <keyword>Adaptive strategies</keyword>
  <keyword>Dynamic regime</keyword>
  <keyword>Sequentially randomized trial</keyword>
  <keyword>Sequential multiple assignment randomized trial</keyword>
  <keyword>Engagement in care</keyword>
  <keyword>Kenya</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

